Description
A CYP17 inhibitor (IC50 = 300 nM) that competitively blocks synthetic androgen binding (EC50 = 845 nM) and antagonizes the androgen receptor in transcriptional activation assays; inhibits the growth of castration-resistant prostate cancer cells (IC50 = 2.9 µM)
Formal name: 17-(1H-benzimidazol-1-yl)-androsta-5,16-dien-3β-ol
Synonyms: TOK-001
Molecular weight: 388.6
CAS: 851983-85-2
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Cytochrome P450||Product Type|Biochemicals|Small Molecule Inhibitors|Sterol Biosynthesis||Research Area|Cancer||Research Area|Endocrinology & Metabolism|Hormones & Receptors|Androgens||Research Area|Lipid Biochemistry|Cytochrome P450 Pathways||Research Area|Lipid Biochemistry|Sterol Lipids